BD 2651910 - PowerLoc PAK Safety Infusion Set, 19G x 1", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2651910 - PowerLoc PAK Safety Infusion Set, 19G x 1", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2651910 PowerLoc PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible surgically implanted vascular ports. The set features a 19-gauge non-coring needle with a 1-inch length and is configured without a Y-injection site, providing a direct fluid pathway for compatible vascular-access procedures.

The PowerLoc system supports administration of compatible medications and fluids, blood specimen withdrawal, implanted port flushing, and power injection through appropriately rated vascular access systems. The 19-gauge configuration provides a larger fluid pathway for applications requiring higher flow capability, while the 1-inch needle length accommodates implanted ports positioned at a moderate depth beneath the skin.

An integrated safety mechanism is designed to help reduce accidental needlestick exposure during port deaccessing. As the needle is removed, the safety system shields the needle point and locks it into a protected position, supporting safer handling, transportation, and disposal.

The low-profile PowerLoc design supports dressing placement, access-site visibility, and patient care. Its ergonomic winged configuration provides controlled access and stabilization during insertion and removal.

The PAK presentation provides an organized, all-in-one solution intended to simplify the multi-step sterile port-access preparation process. BD 2651910 is supplied five sets per case.

Key Benefits

• 19-gauge non-coring needle supports access to compatible implanted vascular ports.
• One-inch needle length accommodates ports positioned at a moderate depth beneath the skin.
• Power-injectable design supports compatible contrast-enhanced diagnostic imaging procedures.
• Compatible 19-gauge PowerLoc configurations support power-injection flow rates up to 5 mL per second when the complete system is appropriately rated.
• Configuration without a Y-injection site provides a direct fluid pathway.
• Non-coring needle design helps minimize unnecessary damage to the implanted port septum.
• Integrated safety mechanism shields and secures the needle point following removal.
• Safety lockout supports occupational needlestick-prevention practices.
• Low-profile design helps facilitate dressing application and access-site management.
• Small footprint supports improved visibility around the port-access site.
• Ergonomic winged design supports controlled insertion and stabilization.
• Compatible with appropriate dual-lumen implanted port applications.
• Suitable for compatible infusion therapy, blood sampling, port maintenance, and power-injection procedures.
• PAK configuration helps organize essential components used during sterile port-access preparation.
• Five-per-case packaging supports controlled clinical inventory management.

Compatibility and Applications

The BD 2651910 PowerLoc PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood product administration, long-term infusion therapy, blood specimen collection, implanted port flushing, and contrast-media delivery during compatible diagnostic imaging procedures.

The 19-gauge needle may be selected when higher flow capability is required and the implanted port, prescribed therapy, and complete fluid pathway are compatible with a larger-gauge port-access device. Selection should consider fluid or medication viscosity, required flow rate, infusion equipment, port specifications, and professional clinical judgment.

The 1-inch needle length may be appropriate when a 0.75-inch needle does not provide sufficient depth but a 1.5-inch configuration would provide unnecessary additional length. Clinicians should assess the patient's tissue depth and implanted port position before selecting the access needle.

The set is configured without a Y-injection site. This direct configuration may be appropriate when the planned therapy does not require an additional secondary medication or fluid-access point within the tubing.

For power injection, the implanted port, access needle, tubing, connectors, and every other component within the fluid pathway must be appropriately rated for the intended powered procedure. The lowest-rated component determines the maximum allowable pressure and flow rate.

Compatibility should be confirmed with the exact implanted port model, septum design, port depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 2651910 should be used only by healthcare professionals trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status when applicable.
• Assess the location and depth of the implanted port before selecting the 1-inch needle.
• Verify that the 19-gauge configuration is appropriate for the intended infusion or imaging procedure.
• Confirm that a configuration without a Y-injection site is suitable for the planned clinical workflow.
• Inspect the sterile package for punctures, moisture, damage, contamination, or compromised integrity.
• Prepare the implanted port site according to institutional skin antisepsis and sterile-access procedures.
• Prime the infusion pathway completely with an approved solution before accessing the port.
• Remove air from the complete fluid pathway before connection.
• Stabilize the implanted port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate contact with the base of the port reservoir is achieved.
• Verify correct placement according to institutional policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and facility protocol.
• Position and secure the tubing to minimize pulling, twisting, pressure, and dressing disruption.
• Apply an approved sterile dressing and maintain appropriate access-site visualization.
• Monitor the site for pain, swelling, redness, leakage, displacement, or other complications.
• Confirm power-injection eligibility before connecting the system to a power injector.
• Do not exceed 5 mL per second or the lower operating limit of any component within the complete system.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and activating the integrated safety mechanism.
• Confirm that the needle is fully secured in the protected position before handling.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the port-access system if resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, or another abnormality develops at the access site.

Certifications and Safety Standards

The BD 2651910 PowerLoc PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The product should be incorporated into facility procedures covering implanted port assessment, sterile preparation, skin antisepsis, port access, infusion administration, connection management, dressing care, power injection, deaccessing, and sharps disposal.

The integrated safety mechanism is designed to shield and secure the needle point following removal from the implanted port. This feature supports occupational needlestick-prevention practices but does not replace appropriate clinician training, personal protective equipment, safe sharps handling, exposure-control procedures, or immediate disposal in an approved sharps container.

The non-coring needle is designed to access the septum of a compatible implanted vascular port while helping minimize unnecessary septum damage when used correctly. Needle gauge and length should be selected according to patient anatomy, port depth, prescribed therapy, required flow characteristics, and current manufacturer instructions.

Healthcare organizations should review current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, shelf life, material composition, natural rubber latex status, DEHP information, maximum pressure, flow-rate specifications, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional implanted port needles without integrated safety technology, the BD PowerLoc system incorporates a mechanism designed to shield and secure the needle after deaccessing. This can help reduce accidental needlestick exposure between needle removal and final sharps disposal.

Compared with port-access sets containing a Y-injection site, BD 2651910 provides a direct fluid pathway without an additional secondary access point. This may simplify the tubing configuration when secondary medication administration is not required.

Compared with non-power-injectable port-access needles, the PowerLoc platform supports compatible power-injection procedures when used with an appropriately rated implanted port and complete fluid pathway.

Compared with 20-gauge and 22-gauge configurations, the 19-gauge needle provides a larger fluid pathway that may be preferred when higher flow capability is required. The larger needle profile should be selected only when appropriate for the implanted port, patient anatomy, and prescribed procedure.

Compared with a 0.75-inch needle, the 1-inch configuration accommodates ports positioned at a greater depth beneath the skin. Compared with a 1.5-inch needle, it may provide a lower profile when additional length is unnecessary.

Compared with loose individual port-access supplies, the PAK presentation organizes essential procedural components into a convenient solution. This can help simplify preparation and promote consistency across clinicians and treatment environments.

Alternative safety infusion sets may vary in gauge, needle length, power-injection capability, safety activation method, wing design, tubing configuration, Y-site availability, included procedural components, and packaging quantity. BD 2651910 combines a 19-gauge, 1-inch non-coring needle with power-injection capability, integrated safety technology, a direct no-Y-site configuration, and organized PAK presentation.

Typical User Profile and Application Scenarios

The BD 2651910 PowerLoc PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified clinical personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port requires a 1-inch access needle and whose prescribed therapy or diagnostic procedure is compatible with a 19-gauge device.

Typical application scenarios include chemotherapy administration, antibiotic infusion, hydration, parenteral nutrition, blood product administration, blood specimen collection, routine implanted port maintenance, and power injection of contrast media during compatible imaging procedures.

The configuration without a Y-injection site is particularly relevant for workflows that use a direct connection and do not require secondary medication or fluid access through the infusion tubing.

Best Practices for Use and Maintenance

The BD 2651910 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on correct storage, product selection, sterile preparation, implanted port access, site monitoring, safety activation, and disposal.

• Store unopened sets according to the environmental conditions specified by the manufacturer.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2651910 catalog number before opening the package.
• Confirm the 19-gauge size, 1-inch needle length, and configuration without a Y-injection site.
• Assess the patient's tissue depth and implanted port position before selecting the needle length.
• Confirm that the required therapy, fluid characteristics, and flow rate are appropriate for a 19-gauge device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the complete fluid pathway before accessing the implanted port.
• Stabilize the implanted port during both needle insertion and removal.
• Position the tubing to avoid unnecessary pulling, twisting, or pressure at the access site.
• Monitor the port site and all tubing connections throughout therapy.
• Verify the power-injectable status of the complete system before any powered procedure.
• Never exceed the lowest pressure or flow-rate limit of any connected component.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse, clean, resterilize, or reprocess the single-use device.
• Confirm complete safety lockout immediately after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2651910 PowerLoc PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 19-gauge size, 1-inch needle length, no-Y-site configuration, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every connected component are specifically approved for the intended power-injection procedure. The permitted pressure, flow rate, contrast-media characteristics, and other operating conditions must be confirmed before use.

Compatible 19-gauge PowerLoc configurations support power injection up to 5 mL per second under manufacturer-specified conditions. The lowest-rated component within the complete system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may contribute to infiltration, extravasation, tissue injury, leakage, implanted port damage, interrupted therapy, or other complications.

Because this configuration does not include a Y-injection site, it does not provide a secondary access point within the tubing. Clinical teams should confirm that a direct fluid pathway is appropriate for the planned therapy before opening the package.

The integrated safety mechanism should be activated according to current manufacturer instructions. The used device remains a contaminated sharp following deaccessing and must be discarded immediately in an approved sharps container.

The product is supplied five sets per case. CIA Medical lists this configuration as temperature sensitive, non-returnable, and restricted to continental United States distribution. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, order quantity, and applicable return conditions before purchasing.

How to Order

Select the BD 2651910 - PowerLoc PAK Safety Infusion Set without Y-Injection Site, 19G x 1" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.